新闻/Reuters/Glenmark Pharma Says Unit IGI Submits IND Application To U.S. FDA For ISB 2301 Targeting Solid TumorsGlenmark Pharma Says Unit IGI Submits IND Application To U.S. FDA For ISB 2301 Targeting Solid Tumors阅读全文在TradingView,您可以无限访问来自Reuters和所有其他新闻来源的文章。继续阅读